166 related articles for article (PubMed ID: 32385852)
21. A Greek family with a follicular variant of familial papillary thyroid carcinoma: TCO, MNG1, fPTC/PRN, and NMTC1 excluded as susceptibility loci.
Tsilchorozidou T; Vafiadou E; Yovos JG; Romeo G; McKay J; Lesueur F; Bonora E
Thyroid; 2005 Dec; 15(12):1349-54. PubMed ID: 16405407
[TBL] [Abstract][Full Text] [Related]
22. Clinical behavior and genetics of nonsyndromic, familial nonmedullary thyroid cancer.
Bauer AJ
Front Horm Res; 2013; 41():141-8. PubMed ID: 23652675
[TBL] [Abstract][Full Text] [Related]
23. Clinical features and genetic predisposition to hereditary nonmedullary thyroid cancer.
Vriens MR; Suh I; Moses W; Kebebew E
Thyroid; 2009 Dec; 19(12):1343-9. PubMed ID: 20001717
[TBL] [Abstract][Full Text] [Related]
24. [Clinical and biological features of familial nonmedullary thyroid carcinoma].
Gao J; Yu Y; Li X; Zhao J; Zhao C; Zhao J; Liu Y; Li Y; Gao M
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):202-6. PubMed ID: 24785281
[TBL] [Abstract][Full Text] [Related]
25. Distinct loci on chromosome 1q21 and 6q22 predispose to familial nonmedullary thyroid cancer: a SNP array-based linkage analysis of 38 families.
Suh I; Filetti S; Vriens MR; Guerrero MA; Tumino S; Wong M; Shen WT; Kebebew E; Duh QY; Clark OH
Surgery; 2009 Dec; 146(6):1073-80. PubMed ID: 19958934
[TBL] [Abstract][Full Text] [Related]
26. [A Familial Non Medullary Thyroid Carcinoma (FNMTC) : a clinical and genetic update].
Valdes-Socin H; Palmeira L; Burlacu MC; Daly AF; Bours V; Beckers A
Rev Med Liege; 2016 Dec; 71(12):557-561. PubMed ID: 28387096
[TBL] [Abstract][Full Text] [Related]
27. A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2.
Canzian F; Amati P; Harach HR; Kraimps JL; Lesueur F; Barbier J; Levillain P; Romeo G; Bonneau D
Am J Hum Genet; 1998 Dec; 63(6):1743-8. PubMed ID: 9837827
[TBL] [Abstract][Full Text] [Related]
28. Identification of a novel germline FOXE1 variant in patients with familial non-medullary thyroid carcinoma (FNMTC).
Pereira JS; da Silva JG; Tomaz RA; Pinto AE; Bugalho MJ; Leite V; Cavaco BM
Endocrine; 2015 May; 49(1):204-14. PubMed ID: 25381600
[TBL] [Abstract][Full Text] [Related]
29. Identification of
Jiang YJ; Xia Y; Hu YX; Han ZJ; Guo AY; Huang T
Thyroid; 2024 May; 34(5):583-597. PubMed ID: 38411500
[No Abstract] [Full Text] [Related]
30. Clinical characteristics and outcome of familial nonmedullary thyroid cancer: a retrospective controlled study.
Robenshtok E; Tzvetov G; Grozinsky-Glasberg S; Shraga-Slutzky I; Weinstein R; Lazar L; Serov S; Singer J; Hirsch D; Shimon I; Benbassat C
Thyroid; 2011 Jan; 21(1):43-8. PubMed ID: 20954815
[TBL] [Abstract][Full Text] [Related]
31. Germline HABP2 Mutation Causing Familial Nonmedullary Thyroid Cancer.
Gara SK; Jia L; Merino MJ; Agarwal SK; Zhang L; Cam M; Patel D; Kebebew E
N Engl J Med; 2015 Jul; 373(5):448-55. PubMed ID: 26222560
[TBL] [Abstract][Full Text] [Related]
32. Penetrance of a rare familial mutation predisposing to papillary thyroid cancer.
Saporito D; Brock P; Hampel H; Sipos J; Fernandez S; Liyanarachchi S; de la Chapelle A; Nagy R
Fam Cancer; 2018 Jul; 17(3):431-434. PubMed ID: 29027612
[TBL] [Abstract][Full Text] [Related]
33. Identification of somatic TERT promoter mutations in familial nonmedullary thyroid carcinomas.
Marques IJ; Moura MM; Cabrera R; Pinto AE; Simões-Pereira J; Santos C; Menezes FD; Montezuma D; Henrique R; Rodrigues Teixeira M; Leite V; Cavaco BM
Clin Endocrinol (Oxf); 2017 Oct; 87(4):394-399. PubMed ID: 28502101
[TBL] [Abstract][Full Text] [Related]
34. Familial nonmedullary thyroid carcinoma.
Mazeh H; Sippel RS
Thyroid; 2013 Sep; 23(9):1049-56. PubMed ID: 23734600
[TBL] [Abstract][Full Text] [Related]
35. Mutant MYO1F alters the mitochondrial network and induces tumor proliferation in thyroid cancer.
Diquigiovanni C; Bergamini C; Evangelisti C; Isidori F; Vettori A; Tiso N; Argenton F; Costanzini A; Iommarini L; Anbunathan H; Pagotto U; Repaci A; Babbi G; Casadio R; Lenaz G; Rhoden KJ; Porcelli AM; Fato R; Bowcock A; Seri M; Romeo G; Bonora E
Int J Cancer; 2018 Oct; 143(7):1706-1719. PubMed ID: 29672841
[TBL] [Abstract][Full Text] [Related]
36. Targeted DNA Sequencing Detects Mutations Related to Susceptibility among Familial Non-medullary Thyroid Cancer.
Yu Y; Dong L; Li D; Chuai S; Wu Z; Zheng X; Cheng Y; Han L; Yu J; Gao M
Sci Rep; 2015 Nov; 5():16129. PubMed ID: 26530882
[TBL] [Abstract][Full Text] [Related]
37. Familial nonmedullary thyroid cancer.
Sturgeon C; Clark OH
Thyroid; 2005 Jun; 15(6):588-93. PubMed ID: 16029126
[TBL] [Abstract][Full Text] [Related]
38. Lack of Mutations in POT1 Gene in Selected Families with Familial Non-Medullary Thyroid Cancer.
Orois A; Badenas C; Reverter JL; López V; Potrony M; Mora M; Halperin I; Oriola J
Horm Cancer; 2020 Apr; 11(2):111-116. PubMed ID: 32172474
[TBL] [Abstract][Full Text] [Related]
39. Clinical characteristics and prognosis of familial nonmedullary thyroid carcinoma.
de Carlos Artajo J; Irigaray Echarri A; García Torres J; Pineda Arribas JJ; Ernaga Lorea A; Eguílaz Esparza N; Zubiría Gortázar JM; Anda Apiñániz E
Endocrinol Diabetes Nutr (Engl Ed); 2022 Apr; 69(4):262-270. PubMed ID: 35353680
[TBL] [Abstract][Full Text] [Related]
40. C14orf93 (RTFC) is identified as a novel susceptibility gene for familial nonmedullary thyroid cancer.
Liu C; Yu Y; Yin G; Zhang J; Wen W; Ruan X; Li D; Zhang S; Cai W; Gao M; Chen L
Biochem Biophys Res Commun; 2017 Jan; 482(4):590-596. PubMed ID: 27864143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
